- Home
- MREO vs NCTY Comparison
MREO vs NCTY Comparison
Compare MREO & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | NCTY |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 45.7M |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MREO | NCTY |
|---|---|---|
| Price | $0.28 | $2.63 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $1.97 | N/A |
| AVG Volume (30 Days) | ★ 624.0K | 56.7K |
| Earning Date | 11-17-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $2.50 |
| 52 Week High | $2.37 | $8.36 |
Technical Indicators
Market Signals| Indicator | MREO | NCTY |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 31.48 |
| Support Level | $0.27 | N/A |
| Resistance Level | $0.35 | $5.48 |
| Average True Range (ATR) | 0.02 | 0.22 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 20.85 | 23.47 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Online game services, out of which Crypto mining business derives maximum revenue.